TrialJournal of thrombosis and haemostasis : JTH2020

Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study.

Paul Knoebl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.